Tuesday, april 27 anatomy - Experimental Biology

tuesday
C17 956.6 High intravascular pressure decreases
endothelial Ca 2+ pulsars and impairs endothelium-dependent
vasodilation in mouse mesenteric arteries. S.K. Sonkusare,
T.J. Heppner, A.D. Bonev, R.M. Hannah, Y. Talline, M.I.
Kotlikoff and M.T. Nelson. Univ. of Vermont and Cornell Univ.
C18 956.7 Cyclic AMP response element binding protein,
Creb, induces endothelial cell proliferation and angiogenesis
in response to thrombin. K.R. Chava and D. Mehta. Univ. of
illinois at Chicago.
C19 956.8 High molecular weight kininogen regulates
endothelial function. D.S. Kolte, N. Osman, J. Yang and Z.
Shariat-Madar. Univ. of Mississippi.
957. Coronary and Cerebral Artery
Endothelial Function
Poster
Tu e. 7:30 a m—An a h e i m Co n v e n t i o n Ce n t e r, Ex h i b it Ha l l CD
Presentation time: 12:30 p m-2:45 p m
C20 957.1 Rapid estrogen signaling via GPER in human
coronary artery smooth muscle. G. Han, H. Ma, S.A. Barman,
M. Sellers, X. Yu, J.N. Stallone and R.E. White. Texas A&M
Univ. and Med. Col. of Georgia.
C21 957.2 Nitric oxide synthase and soluble guanylyl
cyclase activation are required for hypoxic endotheliumdependent
contractions of the porcine coronary artery. C.K.Y.
Chan, J.C.W. Mak, R.Y.K. Man and P.M. Vanhoutte. Univ. of
Hong Kong.
C22 957.3 Melatonin inhibits NO-induced cGMP
accumulation by increasing PDE5 phosphorylation in coronary
arteries. P. Shukla, A. Grazul-Bilska and S.T. O’Rourke.
North Dakota State Univ.
C23 957.4 Coronary endothelium: new pharmacological
target for heart hypertrophy/failure. X. Sun and D.D. Ku. Univ.
of Alabama at Birmingham.
C24 957.5 Adiponectin is secreted by vascular smooth
muscle cells and regulates muscle contractile phenotype. M.
Ding, R.J. Wagner and K.A. Martin. Dartmouth Col. and Yale
Univ.
C25 957.6 Regulation of cerebral blood flow by hydrogen
sulfide. G. Ahmed, A.O. Oyekan and M.A. Yakubu. Texas
Southern Univ. Col. of Pharm. & Hlth. Sci. and Texas Southern
Univ.
C26 957.7 Possible involvement of cytoskeletal reorganization
in PKC-induced cerebroarterial constriction. A.F. El-
Yazbi. Univ. of Calgary.
958. Role of Adenosine Receptors in
Vascular Function
Poster
Tu e. 7:30 a m—An a h e i m Co n v e n t i o n Ce n t e r, Ex h i b it Ha l l CD
Presentation time: 12:30 p m-2:45 p m
C27 958.1 Role of A 1
adenosine receptors in vascular
reactivity and inflammation in a murine model of allergic asthma.
D.S. Ponnoth, A. Nadeem, S. Tilley and S.J. Mustafa. West
Virginia Univ. and Univ. of North Carolina at Chapel Hill.
C28 958.2 Evidence for the role of A 2B
adenosine receptor
in the regulation of vascular tone using A 2B
KO mice. M. Sharifi
Sanjani, D.S. Ponnoth, K. Roush, S. Tilley and S.J. Mustafa.
West Virginia Univ. and Univ. of North Carolina at Chapel Hill.
pHarmacology
C29 958.3 Exaggerated vasoconstriction depends on
w-hydroxyylase through adenosine A 1
receptor in A 1
WT
compared to A 1
KO mouse aorta. S.S. Kunduri, M.A. Nayeem,
J.R. Falck, J. Schnermann and S.J. Mustafa. West Virginia
Univ., Univ. of Texas Southwestern Med. Ctr. and NIDDK, NIH.
C30 958.4 The involvement of PPARa in epoxide-induced
activation of adenosine receptors in angiogenesis. Y.Q. Rizvi,
M. Choi, C. Mehta and A.O. Oyekan. Texas Southern Univ.
959. Role of Nitric Oxide in Vascular
Function
Poster
Tu e. 7:30 a m—An a h e i m Co n v e n t i o n Ce n t e r, Ex h i b it Ha l l CD
Presentation time: 12:30 p m-2:45 p m
C31 959.1 Interaction between sympathomimetic amines,
ephedrine, tyramine and norepinephrine at uptake 1 in
sympathetic nerves and the role of nitric oxide. J.A. Simaan.
American Univ. of Beirut.
C32 959.2 p38 MAPK inhibition prevents angiotensin
II-induced elevation of arginase activity and impaired
vasorelaxation. A. Shatanawi, M.J. Romero, S. Chandra, L.
Yao, H. Flores Toque, J.A. Iddings, R.B. Caldwell and R.W.
Caldwell. Med. Col. of Georgia.
C33 959.3 Mechanisms of AVE3085 against asymmetrical
dimethylarginine-induced endothelial dysfunction. H-M. Xue,
G-W. He, J-H. Huang and Q. Yang. Chinese Univ. of Hong
Kong, Nankai Univ & TEDA Cardiovasc Hosp, Tianjin, People’s
Republic of China and Providence Heart & Vasc. Inst., Oregon
Univ. & Hlth. Sci.
C34 959.4 Peroxynitrite and hydrogen peroxide increase
arginase activity through the RhoA/Rho kinase pathway. S.
Chandra, M.J. Romero, A. Shatanawi, R.B. Caldwell and
R.W. Caldwell. Med. Col. of Georgia.
C35 959.5 Genetic inactivation of endothelial nitric oxide
synthase enhances vasodilator effect of cilostazol. A.V.R.
Santhanam, M.G. Hire, L.A. Smith and Z.S. Katusic. Mayo
Clin. Col. of Med.
C36 959.6 A novel signaling pathway for high output
eNOS-derived nitric oxide in inflamed endothelial cells. J.L.
Lowry, V. Brovkovych, Y. Zhang and R.A. Skidgel. Univ. of
Illinois at Chicago.
C37 959.7 Impaired l-arginine recycling induces
compensatory mechanisms in NO-dependent vessels. R.
Chennupati, B.J.A. Janssen, W.H. Lamers, J.G.R. De Mey
and S.E. Koehler. Maastricht Univ., Netherlands.
C38 959.8 Phosphorylation of endothelial nitric oxide
synthase is increased in mouse model of GTP-cyclohydrolase
I deficiency. L.V. d’Uscio and Z.S. Katusic. Mayo Clin.
C39 959.9 Nitroglycerin reduces TNF-a toxicity to
endothelial cells but compromises the protective effects of
propofol. H-m. Liu, S. Lei, T. Luo, Z-y. Xia, Y. Liu, G.P. Leung,
P.M. Vanhoutte, M.G. Irwin and Z. Xia. Univ. of Hong Kong
and Renmin Hosp., Wuhan Univ., People’s Republic of China.
C40 959.10 Modulation of cyclosporine-induced
hypertension by central endothelial and neuronal nitric oxide
synthases. M.M. El-Mas, A.G. Omar, M.M. Helmy and M.M.
Mohy El-Din. Fac. of Pharm., Univ. of Alexandria, Egypt.
C41 959.11 Pioglitazone ameliorates cyclosporine-induced
attenuation of carbachol renovascular vasodilations: role of
PPARg/nitric oxide synthase signaling. M.M. El-Mas, H.M. El-
Gowelli, E.I. Saad, K.S. Abd-Elrahman and A-G.A. Abdel-
Galil. Fac. of Pharm., Univ. of Alexandria, Egypt.
291
t
u
e